熱門資訊> 正文
中枢制药公司重新获得纳斯达克合规性
2024-09-12 21:14
- CNS Pharmaceuticals (NASDAQ:CNSP) said it has received a notice from the Nasdaq, stating that the company has regained compliance with the equity requirement.
- Press Release
More on CNS Pharmaceuticals
- CNS Pharmaceuticals announces pricing of registered direct offering and concurrent private placement
- CNS Pharmaceuticals drops 6%, prices $1.37M offering
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。